J. Street

2.1k total citations · 1 hit paper
29 papers, 1.6k citations indexed

About

J. Street is a scholar working on Psychiatry and Mental health, Physiology and Pharmacology. According to data from OpenAlex, J. Street has authored 29 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Psychiatry and Mental health, 5 papers in Physiology and 4 papers in Pharmacology. Recurrent topics in J. Street's work include Schizophrenia research and treatment (13 papers), Dementia and Cognitive Impairment Research (9 papers) and Treatment of Major Depression (4 papers). J. Street is often cited by papers focused on Schizophrenia research and treatment (13 papers), Dementia and Cognitive Impairment Research (9 papers) and Treatment of Major Depression (4 papers). J. Street collaborates with scholars based in United States and United Kingdom. J. Street's co-authors include Gary D. Tollefson, R. Tamura, Charles M. Beasley, P.V. Tran, W. Scott Clark, Alan Breier, Peter D. Feldman, Jacobo Mintzer, Donna Masterman and Jeffrey L. Cummings and has published in prestigious journals such as American Journal of Psychiatry, Biological Psychiatry and Neurobiology of Aging.

In The Last Decade

J. Street

28 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: results of an international collaborative trial

1997 693 citations Gary D. Tollefson, Charles M. Beasley et al. American Journal of Psychiatry profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J. Street United States	10	1.4k	354	278	210	203	29	1.6k
Michael J. Sernyak United States	26	1.3k 1.0×	219 0.6×	305 1.1×	229 1.1×	108 0.5×	58	1.9k
Georges M. Gharabawi United States	27	1.5k 1.1×	455 1.3×	399 1.4×	352 1.7×	166 0.8×	50	2.1k
Caroline Corves Germany	6	1.7k 1.2×	311 0.9×	360 1.3×	369 1.8×	130 0.6×	11	2.2k
Heike Hunger Germany	13	1.5k 1.1×	273 0.8×	282 1.0×	245 1.2×	163 0.8×	14	1.9k
Michael D. Jibson United States	17	944 0.7×	169 0.5×	280 1.0×	154 0.7×	103 0.5×	57	1.5k
Ibrahim Turkoz United States	22	1.3k 1.0×	566 1.6×	411 1.5×	199 0.9×	120 0.6×	98	1.8k
Jennifer Hoblyn United States	17	935 0.7×	243 0.7×	179 0.6×	121 0.6×	66 0.3×	32	1.4k
Matthias J. Müller Germany	28	1.0k 0.7×	368 1.0×	304 1.1×	145 0.7×	122 0.6×	61	1.9k
S. Leucht Germany	11	1.7k 1.3×	308 0.9×	555 2.0×	593 2.8×	115 0.6×	19	2.2k
Pierre V. Trân United States	17	1.5k 1.1×	616 1.7×	297 1.1×	304 1.4×	144 0.7×	28	1.9k

Countries citing papers authored by J. Street

Since Specialization

Citations

This map shows the geographic impact of J. Street's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Street with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Street more than expected).

Fields of papers citing papers by J. Street

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Street. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Street. The network helps show where J. Street may publish in the future.

Co-authorship network of co-authors of J. Street

This figure shows the co-authorship network connecting the top 25 collaborators of J. Street. A scholar is included among the top collaborators of J. Street based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Street. J. Street is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Street, J., et al.. (2012). Fusobacterium necrophorum in an Abdominal Aortic Aneurysm, Treated by Once Daily Ertapenem. International Journal of Angiology. 21(3). 175–176.

Tariot, Pierre N., Lon S. Schneider, Ira R. Katz, et al.. (2006). Quetiapine Treatment of Psychosis Associated With Dementia: A Double-Blind, Randomized, Placebo-Controlled Clinical Trial. American Journal of Geriatric Psychiatry. 14(9). 767–776. 103 indexed citations

Cummings, Jeffrey L., J. Street, Donna Masterman, & W. Scott Clark. (2002). Efficacy of Olanzapine in the Treatment of Psychosis in Dementia with Lewy Bodies. Dementia and Geriatric Cognitive Disorders. 13(2). 67–73. 83 indexed citations

Mintzer, Jacobo, Warachal Faison, J. Street, Virginia K. Sutton, & Alan Breier. (2001). Olanzapine in the treatment of anxiety symptoms due to Alzheimer's disease: a post hoc analysis. International Journal of Geriatric Psychiatry. 16(S1). S71–S77. 33 indexed citations

Street, J., et al.. (2001). Long-term efficacy of olanzapine in the control of psychotic and behavioral symptoms in nursing home patients with Alzheimer's dementia. International Journal of Geriatric Psychiatry. 16(S1). S62–S70. 67 indexed citations

Clark, W. Scott, J. Street, Peter D. Feldman, & Alan Breier. (2001). The Effects of Olanzapine in Reducing the Emergence of Psychosis Among Nursing Home Patients With Alzheimer's Disease. The Journal of Clinical Psychiatry. 62(1). 34–40. 77 indexed citations

Sutton, Virginia K., J. Street, John Kennedy, P.D. Feldman, & Alan Breier. (2001). Superiority of olanzapine over risperidone in the control of negative symptoms of schizophrenia and related psychotic disorders in older patients. European Neuropsychopharmacology. 11. S276–S276. 8 indexed citations

Street, J.. (2000). Olanzapine Treatment of Psychotic and Behavioral Symptoms in Patients With Alzheimer Disease in Nursing Care Facilities. Archives of General Psychiatry. 57(10). 968–968. 464 indexed citations

Street, J., et al.. (2000). Long-term efficacy of olanzapine in the control of psychotic and behavioral symptoms in patients with Alzheimer's dementia. Neurobiology of Aging. 21. 242–242. 2 indexed citations

10.

Clark, W. Scott, et al.. (2000). Reduction of psychotic symptoms in patients with lewy body-like symptoms treated with olanzapine. Neurobiology of Aging. 21. 29–29. 2 indexed citations

11.

Street, J., et al.. (2000). Long-term efficacy of olanzapine in the control of psychotic and behavioral symptoms in patients with Alzheimer's dementia. European Neuropsychopharmacology. 10. 365–366. 2 indexed citations

12.

Street, J., et al.. (2000). P01.100 Long-term efficacy of olanzapine in the control of psychotic and behavioral symptoms in patients with alzheimer's dementia. European Psychiatry. 15(S2). 346s–347s. 1 indexed citations

13.

Clark, W. Scott, J. Street, T.M. Sanger, P.D. Feldman, & Alan Breier. (2000). 534. Reduction of psychotic symptoms in patients with Lewy body-like symptoms treated with olanzapine. Biological Psychiatry. 47(8). S163–S163. 1 indexed citations

14.

Clark, W. Scott, J. Street, T.M. Sanger, & Alan Breier. (2000). Olanzapine in the prevention of psychosis among nursing home patients with behavioral disturbances associated with Alzheimer's disease. Neurobiology of Aging. 21. 241–241. 3 indexed citations

15.

Street, J., W. Scott Clark, Kimberley S. Gannon, et al.. (1999). OLANZAPINE REDUCES PSYCHOSIS AND BEHAVIORAL SYMPTOMS ASSOCIATED WITH ALZHEIMER's DISEASE. American Journal of Geriatric Psychiatry. 7. 61–62. 2 indexed citations

16.

Street, J., W. Scott Clark, K.S. Gannon, T.M. Sanger, & Alan Breier. (1999). Reduction of psychotic symptoms in patients with Lewy Body-like symptoms treated with olanzapine. European Neuropsychopharmacology. 9. 331–332. 2 indexed citations

17.

Tollefson, Gary D., et al.. (1997). Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: results of an international collaborative trial. American Journal of Psychiatry. 154(4). 457–465. 693 indexed citations breakdown →

18.

Street, J., Mary Anne Dellva, R. Tamura, T.M. Sanger, & G.D. Tollefson. (1996). A comparison of extrapyramidal syndromes between olanzapine and placebo in shcizophrenia. European Neuropsychopharmacology. 6. S4–122. 3 indexed citations

19.

Street, J., R. Tamura, T.M. Sanger, & G.D. Tollefson. (1996). A comparison of the incidence of long-term treatment-emergent dyskinetic symptoms in patients treated with olanzapine and haloperidol. European Neuropsychopharmacology. 6. S4–122. 3 indexed citations

20.

Sayler, Mary E., J. Street, J C Bosomworth, Janet H. Potvin, & James G. Kotsanos. (1995). Analysis of Mortality in Pergolide-Treated Patients with Parkinson's Disease. Neuroepidemiology. 15(1). 26–32. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact